74 results
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
10 May 24
Longeveron Announces Board of Directors Planned Transitions
4:30pm
healthcare investment banker at William Blair, Truist, and Oppenheimer and Company, also has been nominated as a candidate for the Board, subject … of Directors has also nominated Roger Hajjar, MD, former head of R&D at Ring Therapeutics, and Neha Motwani, a former senior healthcare investment banker
8-K
EX-99.1
LGVN
Longeveron Inc - Ordinary Shares
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
institutions to conduct our clinical trials; ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on our
8-K
EX-99.2
LGVN
Longeveron Inc - Ordinary Shares
18 Apr 24
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4:30pm
trials; ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on our business and results of operations; if we
424B4
LGVN
Longeveron Inc - Ordinary Shares
17 Apr 24
Prospectus supplement with pricing info
5:07pm
commercialization, and broad use by the healthcare community.
In November of 2023, Longeveron received notice from the World Health Organization (“WHO … . This has placed tremendous strain on healthcare systems in the management of aging-related ailments and presents additional socioeconomic consequences
8-K
EX-99.2
2md7c77y0 70bja
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
8-K
EX-99.1
yb9c795y
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
424B4
ho51 rtqbamit
10 Apr 24
Prospectus supplement with pricing info
7:48am
FWP
r6494rvaf6f w8p
8 Apr 24
Free writing prospectus
8:45am
8-K
EX-99.1
4x617d z0jdginukxx
19 Mar 24
Longeveron Announces 1-for-10 Reverse Stock Split
4:01pm
424B5
xbdc1 nay0cpiejwiat
22 Dec 23
Prospectus supplement for primary offering
8:36am
424B3
z2thtivf
6 Dec 23
Prospectus supplement
4:05pm